ARO-APOC3 (Plozasiran)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ARO-APOC3 (Plozasiran), covering 2026-02-04 to 2026-02-04. Get the full timeline:
Most recent: Clinical Trial Update: Study of ARO-APOC3 (Plozasiran) in Adults With Familial Chylomicronemia Syndrome (FCS) [Phase 3]